ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.
Metrics to compare | ZIML | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZIMLPeersSector | |
---|---|---|---|---|
P/E Ratio | 36.6x | 35.1x | −0.7x | |
PEG Ratio | −0.79 | 0.15 | 0.00 | |
Price/Book | 1.4x | 3.6x | 2.6x | |
Price / LTM Sales | 0.9x | 3.4x | 3.4x | |
Upside (Analyst Target) | - | 16.4% | 35.7% | |
Fair Value Upside | Unlock | −2.3% | 4.1% | Unlock |